Hybrid Amphotericin B derivatives with reduced toxicity

Martin D. Burke (Inventor), Anuj Khandelwal (Inventor), Jiabao Zhang (Inventor), Anna SantaMaria (Inventor)

Research output: Patent


Disclosed are derivatives of amphotericin B (AmB) characterized by improved clinical efficacy with reduced toxicity compared to AmB. Also disclosed are pharmaceutical compositions comprising the AmB derivatives, therapeutic methods of using the AmB derivatives and methods of making the AmB derivatives.
Original languageEnglish (US)
U.S. patent number11198705
Filing date9/6/19
StatePublished - Dec 14 2021


Dive into the research topics of 'Hybrid Amphotericin B derivatives with reduced toxicity'. Together they form a unique fingerprint.

Cite this